
In episode 2 of The Life & Science Podcast, we sit down with Joe Beechem for a celebration of four decades in science: why he left a tenured academic career to “build a box that people around the world can use”, and what it took to bring spatial biology to the world.
Joe’s path runs from a commuter school to Johns Hopkins, a physics postdoc, and a tenured chair in a medical school. From there he went to Molecular Probes, Life Technologies and NanoString, where he led R&D through the launch of GeoMx and CosMx. He lived through a very public patent fight, a Chapter 11 and the sale to Bruker. And he’s still not done: his next project is spatial proteomics.
We discuss:
- The Friday-night phone call that made him leave academia, and why he has no regrets
- How a cold call to Johns Hopkins got him into grad school
- The masking-tape and pipette experiment that became GeoMx, and the pathologist survey that nearly killed it
- Living through litigation and bankruptcy
- The two paths to the clinic: discovery-first biomarkers and foundation models
- Why big companies lose their innovation engine, and his next move in spatial proteomics
- The Socratic play he’s writing for non-scientists, with Darwin, Rosalind Franklin and Carl Sagan
If you build or buy spatial tools, run a lab, or wonder what a long career in this field looks like from the inside, this one is for you.
Chapters
0:00 Meet Joe Beechum
0:35 20,000 miles in one tour
1:32 Mr. NanoString, Mr. Spatial
4:16 The idea behind high-plex microscopy
6:30 A tenured professor who couldn't stop building
8:35 The call that led to leaving Vanderbilt
11:15 No regrets: Vanderbilt and tenure
13:26 Cold-calling Johns Hopkins
16:30 First from northern Kentucky in an Ivy League grad school
18:49 From biology to physics
23:28 Walking into med school
25:33 Molecular Probes and the Alexa Fluor dyes
27:55 The Invitrogen acquisition
30:17 Life Technologies: AGBT plenary, Starlight, Ion Torrent
32:29 Leaving Life Tech and joining NanoString
34:54 A lunch at JP Morgan, a $50M investment
37:22 The engineer who said "it could work": birth of GeoMx
42:06 "Think big, act small"
47:18 "No one will want this": the board says no to GeoMx
49:33 Proving it works: the 84-gene assay
51:51 CosMx: imaging thousands of transcripts
56:38 Best Buzz at AGBT, again and again
57:21 Lawsuits and the road to Chapter 11
58:12 Holding the lab together through Chapter 11
1:01:06 "We're not going anywhere"
1:03:32 Bidding war
1:04:34 The payoff: saving the microscopes
1:06:22 Did he maximize his impact?
1:09:00 Socrates in a black box theater: Joe's play
1:15:03 Anti-science world
1:18:33 The next chapter: proteins
1:20:17 Spatial in the clinic: two paths
1:27:30 Is 3D the next frontier?
1:30:08 RNA or protein? Dinner with Carl Sagan?
1:33:45 Would he do it all again?
1:35:45 The one regret
1:38:06 What he's afraid of
1:39:25 Final advice: look inside, look outside
Does the path to the clinic run through discovery-first biomarkers, foundation models, or both? Tell us in the comments, and follow The Life & Science Podcast for the next episode.
#SpatialBiology #SpatialOmics #Genomics #Proteomics #LifeSciences
#SRC-Search
src-search.com
Flere episoder fra "The Life & Science Podcast"



Gå ikke glip af nogen episoder af “The Life & Science Podcast” - abonnér på podcasten med gratisapp GetPodcast.



